These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6197682)

  • 1. [Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications].
    Volpi A; Piaserico PL
    Minerva Med; 1983 Oct; 74(39):2287-9. PubMed ID: 6197682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria.
    Ahmad J; Singh M; Saleemuddin M
    J Assoc Physicians India; 2001 Nov; 49():1062-5. PubMed ID: 11868856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of analysis of alpha 2-macroglobulin in the diagnosis of diabetic diseases].
    Hanabusa T; Hirayama J; Nanjo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():345-8. PubMed ID: 1707992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coglitore G; Squadrito G
    Minerva Med; 1979 May; 70(22):1601-3. PubMed ID: 88025
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [alpha 2-Macroglobulin].
    Hanabusa T; Nanjo K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():106-8. PubMed ID: 9513397
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes mellitus: the role of metabolic control in the prevention of complications].
    Gomez F; Chabot V
    Schweiz Med Wochenschr; 1983 Sep; 113(38):1342-5. PubMed ID: 6415812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].
    Pawłowski P; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):147-52. PubMed ID: 16232368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency of diabetic microangiopathy in newly diagnosed diabetes mellitus in Conakry: late diagnosis and lack of screening].
    Baldé NM; Kaba ML; Baldé MD; Diallo AO; Goépogui A; Diakité M
    Dakar Med; 2007; 52(3):165-70. PubMed ID: 19097396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency and seasonal biorhythm of metabolic indices and vascular lesions in diabetics].
    Nikberg II; Efimov DA
    Vrach Delo; 1984 Nov; (11):57-60. PubMed ID: 6528561
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alpha-2-macroglobulin in diabetes mellitus].
    Rodríguez Cuartero A; Castillo Higueras PL; Mora Lara RJ; Núñez Carril J
    Rev Clin Esp; 1979 Oct; 155(1):23-5. PubMed ID: 94170
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perspective of proteomic studies for discovering biomarkers of diabetes and obesity].
    Kaburagi Y; Unoki-Kubota H
    Nihon Rinsho; 2012 May; 70(5):769-73. PubMed ID: 22619999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alpha 2-macroglobulin in the blood of patients with diabetes mellitus].
    Turecký L; Kupcová V; Szántová M
    Bratisl Lek Listy; 1999 Jan; 100(1):25-7. PubMed ID: 10492994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a two-year clinico-morphological study of the natural evolution of diabetic microangiopathy and the efficacy of angioprotective therapy].
    Velikov VK; Shubina OI; Saltykov BB; Frolova AI
    Ter Arkh; 1987; 59(11):32-5. PubMed ID: 3441862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute-phase protein reactants pattern and alpha 2-macroglobulin in diabetes mellitus. Pathophysiological aspects in diabetic microangiopathy.
    Solerte SB; Adamo S; Viola C; Carnevale Schianca GP; Crippa A; Ferrari E
    Ric Clin Lab; 1984; 14(3):575-9. PubMed ID: 6084296
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of diabetic microangiopathy and diabetic control. A study in non-insulin-dependent diabetics.
    Maneschi F; Cassar J; Lowy C; Kohner EM
    Diabete Metab; 1981 Sep; 7(3):181-7. PubMed ID: 7033009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
    Long ZF; Qu GY; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.